Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence in Diagnostics Market, by Diagnosis Type
1.4.2 North America Artificial Intelligence in Diagnostics Market, by Component
1.4.3 North America Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Recent Industry Wide Strategic Developments
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Approvals
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.2.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Nov – 2020, Jun) Leading Players
Chapter 4. North America Artificial Intelligence in Diagnostics Market by Diagnosis Type
4.1 North America Radiology Market by Country
4.2 North America Oncology Market by Country
4.3 North America Neurology Market by Country
4.4 North America Cardiology Market by Country
4.5 North America Chest & Lungs Market by Country
4.6 North America Pathology Market by Country
4.7 North America Other Diagnosis Types Market by Country
Chapter 5. North America Artificial Intelligence in Diagnostics Market by Component
5.1 North America Services Market by Country
5.2 North America Software Market by Country
5.3 North America Hardware Market by Country
Chapter 6. North America Artificial Intelligence in Diagnostics Market by Country
6.1 USA Artificial Intelligence in Diagnostics Market
6.1.1 USA Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.2 USA Artificial Intelligence in Diagnostics Market by Component
6.2 Canada Artificial Intelligence in Diagnostics Market
6.2.1 Canada Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.2 Canada Artificial Intelligence in Diagnostics Market by Component
6.3 Mexico Artificial Intelligence in Diagnostics Market
6.3.1 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.2 Mexico Artificial Intelligence in Diagnostics Market by Component
6.4 Rest of North America Artificial Intelligence in Diagnostics Market
6.4.1 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.2 Rest of North America Artificial Intelligence in Diagnostics Market by Component
Chapter 7. Company Profiles
7.1 General Electric (GE) Co. (GE Healthcare)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Approvals:
7.2 Siemens AG (Siemens Healthineers)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Aidoc Medical Ltd.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.2.2 Partnerships, Collaborations, and Agreements:
7.4 AliveCor, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Product Launches and Product Expansions:
7.5 Imagen Technologies, Inc.
7.5.1 Company Overview
7.6 VUNO, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Approvals:
7.7 IDx Technologies, Inc.
7.7.1 Company overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 NovaSignal Corporation
7.8.1 Company Overview
7.9 Riverain Technologies, LLC
7.9.1 Company Overview
7.1 Zebra Medical Vision Ltd.
7.10.1 Company overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.2.2 Approvals:
Unique Offerings 